Shipped cold to your door  ·  Lyophilized vialsQuestions? WhatsApp +62 811 2120 5090
A plate of quinoa and fresh vegetables on a table
Wellness

Retatrutide and Cagrilintide: why these two compounds are paired

16 August 2026

Retatrutide and Cagrilintide are among the most talked-about names in research on metabolism and the feeling of fullness. These two compounds work through two different signaling pathways, and that is exactly the reason they are paired in one product.

This article helps you read the combination page more clearly. For basic context before getting to know these names, Peptides for beginners: where to start can be a useful starting point.

Two different signaling pathways

Retatrutide is discussed within the incretin family, a group of signals related to the regulation of fullness and energy use. Cagrilintide is a long-acting amylin analog. Amylin itself is a hormone released together with insulin by the beta cells of the pancreas, and it works through the amylin and calcitonin receptors.

CompoundPathway discussed
RetatrutideIncretin family
CagrilintideAmylin and calcitonin pathway
Summary of the two pathways discussed in the combination

This difference in the point of action is the core reason the two are paired. The signaling map explains why the idea of a combination came up, which is to touch two sides of fullness regulation at once.

Where the idea of pairing these two pathways comes from

The regulation of fullness involves more than one signal. Because of that, research has already studied the concept of pairing the incretin and amylin pathways, among others with another incretin compound that was studied earlier. That data is the basis for the interest in pairing these two pathways.

On the catalog page, Retatrutide + Cagrilintide is a separate product with its own product information, distinct from Retatrutide on its own.

The research stage of each compound

The series of late-stage clinical trials of Retatrutide has been completed, and the company developing it has reported positive results. Cagrilintide is also being studied in clinical trials, including in a pairing with another incretin compound. The combination of the two in one vial starts from that concept of pairing two pathways.

To understand the research stage and how to read its product information, read Retatrutide in Indonesia: its status and how to read it.

How to read the combination catalog page

Start by checking the contents of the vial and its milligram split as packaging information, not as instructions for use. Then compare it with the page for Retatrutide on its own to see the difference.

Full details on Retatrutide + Cagrilintide and Retatrutide are in the Peptivia catalog. If there is anything you would like to ask before ordering, the Peptivia team is ready to help through Peptivia's official WhatsApp.

Frequently asked questions
Why are Retatrutide and Cagrilintide paired?

The two touch different signaling pathways: Retatrutide in the incretin family, Cagrilintide in the amylin and calcitonin pathway. This pairing touches two sides of fullness regulation at once.

What is the difference between Retatrutide + Cagrilintide and Retatrutide on its own?

Retatrutide on its own contains one compound from the incretin family. The combination product contains Retatrutide together with Cagrilintide, a long-acting amylin analog, in one vial. The contents and milligram split are listed on each product page.

Peptides in this article

Still deciding which one fits? Tell us your goal and we will help you narrow it down.

Chat on WhatsApp